Buy Venus Remedies; target of Rs 360: HEM Securities

“Presently, Venus Remedies is trading at Rs 276.10 which is at 5.11 times to its earnings and 1.63 times to its book value of Rs 169.07. Since the stock offers good opportunity, we initiate a buy signal on the stock with a target price of Rs 360 in medium to long term investment horizon expecting an appreciation of about 30% from the current level of Rs 276.10,” says HEM Securities research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.